Published 2014
| Version v1.0.0
Journal Article
Open
Rituximab in Autoimmune CNS Disease
- Creators
- Millichap, J. Gordon
- Millichap, John J.
Abstract
Investigators at University of Sydney, Australia, and 14 international centers assessed the utility and safety of rituximab in 144 children (median age 8 years, range 0.7-17; 103 female) with autoimmune and inflammatory disorders of the CNS.
Files
PNB-2014-28-8-7.pdf
Files
(99.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:cb52a58ea1d802f609ebc1651cd110cf
|
99.9 kB | Preview Download |
Additional details
- Other
- PNB-2014-28-8-7
- Created
-
2014When the item was originally created.